Serum samples from 317 patients with patients with severe acute respiratory syndrome (SARS) were tested for the nucleocapsid (N) protein of SARS-associated coronavirus, with sensitivities of 94% and 78% for the first 5 days and 6–10 days after onset, respectively. The specificity was 99.9%. N protein can be used as an early diagnostic maker for SARS.
All Keywords
【저자키워드】 SARS-CoV, nucleocapsid protein, monoclonal antibody, enzyme-linked immunosorbent assay, early diagnosis, severe acute respiratory syndrome, dispatch, 【초록키워드】 coronavirus, diagnostic, Protein, sensitivity, specificity, nucleocapsid, Patient, N protein, early, acute respiratory syndrome, serum sample, tested, can be used,
【저자키워드】 SARS-CoV, nucleocapsid protein, monoclonal antibody, enzyme-linked immunosorbent assay, early diagnosis, severe acute respiratory syndrome, dispatch, 【초록키워드】 coronavirus, diagnostic, Protein, sensitivity, specificity, nucleocapsid, Patient, N protein, early, acute respiratory syndrome, serum sample, tested, can be used,